Literature DB >> 12414860

Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men.

Kai Henrik Wiborg Lange1, Benny Larsson, Allan Flyvbjerg, Rolf Dall, Morten Bennekou, Michael Højby Rasmussen, Hans Ørskov, Michael Kjaer.   

Abstract

We studied the acute effects of a single, sc GH dose on exercise performance and metabolism during bicycling. Seven highly trained men [age, 26 +/- 1 yr (mean +/- SEM); weight, 77 +/- 3 kg; maximal oxygen uptake, 65 +/- 1 ml O(2).min(-1).kg(-1)] performed 90 min of bicycling 4 h after receiving 7.5 IU (2.5 mg) GH or placebo in a randomized, double-blinded, cross-over design trial. A standardized pre-exercise meal was given 2 h before exercise. Blood was sampled at rest and during exercise and analyzed for GH, IGF-I, glucose, lactate, insulin, glycerol, and nonesterified fatty acids (NEFA). In the placebo trial, all subjects completed the exercise protocol without any difficulties. In contrast, two subjects were not able to complete the exercise protocol in the GH trial, and one subject barely managed to complete the protocol. In addition, GH administration resulted in exaggerated increases in plasma lactate concentrations during exercise (P < 0.0001). The combined lipolytic effect of GH and exercise, evidenced by increased plasma glycerol and serum NEFA concentrations, was 3-fold greater than the effect of exercise alone (P < 0.0001), but this increased substrate availability did not result in increased whole body fat oxidation (indirect calorimetry). Plasma glucose was, on average, 9% higher during exercise after GH administration compared with placebo (P < 0.0001). We conclude that a single, relevant GH dose causes exaggerated increases in plasma lactate and glycerol as well as serum NEFA during 90 min of subsequent bicycling at moderate to high intensity. The exaggerated increase in plasma lactate may be associated with substantially decreased exercise performance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414860     DOI: 10.1210/jc.2001-011797

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Human growth hormone: a Paul Bunyan drug or a drug for Paul's bunion.

Authors:  George T Griffing
Journal:  MedGenMed       Date:  2007-12-03

2.  Effect of preceding resistance exercise on metabolism during subsequent aerobic session.

Authors:  Jie Kang; Stefanie L Rashti; Christopher P Tranchina; Nicholas A Ratamess; Avery D Faigenbaum; Jay R Hoffman
Journal:  Eur J Appl Physiol       Date:  2009-06-06       Impact factor: 3.078

Review 3.  Regulation of skeletal muscle mitochondrial function: genes to proteins.

Authors:  I R Lanza; K Sreekumaran Nair
Journal:  Acta Physiol (Oxf)       Date:  2010-03-25       Impact factor: 6.311

4.  No effect of growth hormone administration on substrate oxidation during exercise in young, lean men.

Authors:  Mette Hansen; Rikke Morthorst; Benny Larsson; Rolf Dall; Allan Flyvbjerg; Michael Højby Rasmussen; Hans Orskov; Michael Kjaer; Kai Henrik Wiborg Lange
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

5.  Testosterone and growth hormone improve body composition and muscle performance in older men.

Authors:  Fred R Sattler; Carmen Castaneda-Sceppa; Ellen F Binder; E Todd Schroeder; Ying Wang; Shalender Bhasin; Miwa Kawakubo; Yolanda Stewart; Kevin E Yarasheski; Jagadish Ulloor; Patrick Colletti; Ronenn Roubenoff; Stanley P Azen
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

6.  Combined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats.

Authors:  Weng-Lang Yang; Gaifeng Ma; Mian Zhou; Monowar Aziz; Hao-Ting Yen; Spyros A Marvropoulos; Kaie Ojamaa; Ping Wang
Journal:  Mol Med       Date:  2016-01-25       Impact factor: 6.354

7.  Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty.

Authors:  Vanessa A Curtis; David B Allen
Journal:  Sports Health       Date:  2011-01       Impact factor: 3.843

8.  AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects.

Authors:  Michael R Graham; Peter Evans; Bruce Davies; Julien S Baker
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

Review 9.  Growth hormone doping: a review.

Authors:  Ioulietta Erotokritou-Mulligan; Richard Ig Holt; Peter H Sönksen
Journal:  Open Access J Sports Med       Date:  2011-07-27

10.  Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro.

Authors:  James Keane; Lotti Tajouri; Bon Gray
Journal:  Nutr Metab (Lond)       Date:  2016-07-04       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.